{"disease":{"id":"cervical-cancer","name":"Cervical Cancer","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":47},"drugs":{"marketed":[{"drug_id":"tisotumab-vedotin","indication_name":"Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tivdak","generic_name":"tisotumab-vedotin","company_name":"SEAGEN","drug_phase":"marketed","molecular_target":"Tissue factor","drug_class":"Antibody-drug conjugate","quality_score":10,"revenue":"147","mechanism":"Tisotumab vedotin is a tissue factor (TF)-directed antibody drug conjugate that targets and disrupts microtubule networks in cancer cells."},{"drug_id":"tisotumab","indication_name":"recurrent or metastatic cervical cancer with disease progression on or after chemotherapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tivdak","generic_name":"TISOTUMAB","company_name":"Seagen","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":64,"revenue":"147","mechanism":"Tivdak works by binding to a specific target on cancer cells, triggering an immune response to destroy the cancer."},{"drug_id":"tivdak","indication_name":"Treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tisotumab Vedotin","generic_name":"tivdak","company_name":"SEAGEN","drug_phase":"marketed","molecular_target":"Tissue factor","drug_class":"Antibody-Drug Conjugate (ADC)","quality_score":10,"revenue":"147","mechanism":""},{"drug_id":"bevacizumab-maly","indication_name":"Persistent, Recurrent, or Metastatic Cervical Cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"ALYMSYS","generic_name":"BEVACIZUMAB-MALY","company_name":"AMNEAL PHARMS LLC","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"tumor-tissue","indication_name":"Cervical Cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tumor Tissue","generic_name":"tumor-tissue","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07059013","indication_name":"Treatment of certain types of cervical cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pf-07059013","generic_name":"pf-07059013","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"fytic-acid","indication_name":"Lymphoscintigraphy in cervical cancer, uterine neoplasms, vulvar cancer, and head and neck canccer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phyliance","generic_name":"fytic acid","company_name":"PDRadiopharma Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"pembrolizuma","indication_name":"Advanced or recurrent cervical cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pembrolizuma","company_name":"Memorial Sloan Kettering Cancer Center","drug_phase":"marketed","molecular_target":"Programmed cell death protein 1","drug_class":"","quality_score":14,"revenue":null,"mechanism":null},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Cervical cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic cervical cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":10,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06700941","title":"Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment","phase":"","overall_status":"COMPLETED","enrollment_count":8000000,"lead_sponsor_name":"Universidad Nacional de Colombia","has_results":false},{"nct_id":"NCT01267851","title":"Clinical Database and Biobank of Patients With Gynecologic Neoplasms","phase":"","overall_status":"UNKNOWN","enrollment_count":1600000,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06204133","title":"Model Study on Cervical Cancer Screening Strategies and Risk Prediction","phase":"","overall_status":"COMPLETED","enrollment_count":1112846,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT05506800","title":"Guangzhou Women's Health Cohort Study (GWHCS)","phase":"","overall_status":"SUSPENDED","enrollment_count":1000000,"lead_sponsor_name":"Guangzhou Women and Children's Medical Center","has_results":false},{"nct_id":"NCT06440382","title":"Scottish Cervical Screening and Ethnicity Project","phase":"","overall_status":"COMPLETED","enrollment_count":600000,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT04689178","title":"Cervical Cancer Screening Uptake: A Randomised Controlled Trial Assessing the Effect of Sending Invitation Letters to Nonadherent Women","phase":"NA","overall_status":"UNKNOWN","enrollment_count":195000,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT05229679","title":"HPV-based Screening Among Women 23-29 Years of Age","phase":"NA","overall_status":"RECRUITING","enrollment_count":180000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04910802","title":"Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":150000,"lead_sponsor_name":"Miriam Elfström","has_results":false},{"nct_id":"NCT06536855","title":"Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwanda","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Rwanda Biomedical Centre","has_results":false},{"nct_id":"NCT07259616","title":"Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities","phase":"","overall_status":"COMPLETED","enrollment_count":46079,"lead_sponsor_name":"Gynaecologisch Oncologisch Centrum Zuid","has_results":false},{"nct_id":"NCT04371887","title":"Comparing Strategies for Implementing Primary HPV Screening","phase":"NA","overall_status":"UNKNOWN","enrollment_count":45000,"lead_sponsor_name":"Chun Chao","has_results":false},{"nct_id":"NCT06931184","title":"Self- Sampling in Cervical Cancer Routine Screening","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":40000,"lead_sponsor_name":"Tampere University Hospital","has_results":false},{"nct_id":"NCT04111835","title":"HPV Testing In Polish POpulation-based Cervical Cancer Screening Program.","phase":"NA","overall_status":"COMPLETED","enrollment_count":33000,"lead_sponsor_name":"Maria Sklodowska-Curie National Research Institute of Oncology","has_results":false},{"nct_id":"NCT04679675","title":"Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":32771,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT06557954","title":"Cervical Cytology DNA Methylation for Cervical Cancer Screening","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05022511","title":"Three Birds With One Stone","phase":"NA","overall_status":"COMPLETED","enrollment_count":27099,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT03179306","title":"Cervix Image Sharing Protocol (CISP)","phase":"","overall_status":"COMPLETED","enrollment_count":27084,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04061967","title":"Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.","phase":"NA","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04272190","title":"Effect of Different Treatments on the Prognosis of Early Cervical Cancer: A Multicenter, Prospective, Real-world Study","phase":"","overall_status":"UNKNOWN","enrollment_count":20000,"lead_sponsor_name":"Southern Medical University, China","has_results":false},{"nct_id":"NCT04974424","title":"Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV","phase":"","overall_status":"UNKNOWN","enrollment_count":20000,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT01895517","title":"CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":18471,"lead_sponsor_name":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","has_results":false},{"nct_id":"NCT05133661","title":"SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":17602,"lead_sponsor_name":"Jhpiego","has_results":false},{"nct_id":"NCT04551287","title":"Artificial Intelligence Enables Precision Diagnosis of Cervical Cytology Grades and Cervical Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":16164,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT04226313","title":"Self-sampling for Non-attenders to Cervical Cancer Screening","phase":"NA","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"The Institute of Molecular and Translational Medicine, Czech Republic","has_results":false},{"nct_id":"NCT00543543","title":"Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":14840,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05359016","title":"Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique","phase":"NA","overall_status":"RECRUITING","enrollment_count":14600,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05912972","title":"Development and Management of Registry in Patients With Gynecologic Cancer in Korea","phase":"","overall_status":"RECRUITING","enrollment_count":13500,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT04461678","title":"Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit","phase":"NA","overall_status":"COMPLETED","enrollment_count":12230,"lead_sponsor_name":"Becton, Dickinson and Company","has_results":false},{"nct_id":"NCT00092534","title":"Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12167,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04646954","title":"DNA Methylation Testing for the Screening of Uterine Cervical Lesion","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT04312178","title":"Combined Incentive Actions, Focusing on Primary Care, to Improve Cervical Cancer Screening in Women Residing in Socio-economically Disadvantaged and Untracked Geographical Areas: a Hybrid Efficacy and Implementation Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":10446,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT03856684","title":"Evaluation of Three Strategies Based on Vaginal Self-sampling Kit Send to Home of Unscreened Women for Cervical Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":10400,"lead_sponsor_name":"University Hospital, Tours","has_results":false},{"nct_id":"NCT06203106","title":"NYSCF Scientific Discovery Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"New York Stem Cell Foundation Research Institute","has_results":false},{"nct_id":"NCT05309122","title":"Cervical Cancer Screening Strategies","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT06619743","title":"HPV Infection and Vaginal Microecology in Immunosuppressed Women","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Lan Zhu","has_results":false},{"nct_id":"NCT03961178","title":"A Cohort Study for the Following up of Conization","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT03967457","title":"Comprehensive Study on the Quality of Life in Cervical Cancer Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT06815939","title":"Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"DL Analytics","has_results":false},{"nct_id":"NCT06082765","title":"Cervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT06823817","title":"Quality Control of Colposcopy Application","phase":"","overall_status":"COMPLETED","enrollment_count":10000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04537156","title":"Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9327,"lead_sponsor_name":"Xiamen University","has_results":false},{"nct_id":"NCT04096872","title":"Clinical Application of Laparo-endoscopic Single-site Surgery and Natural Orifice Transluminal Endoscopic in Gynecology","phase":"","overall_status":"UNKNOWN","enrollment_count":9000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06082505","title":"Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 1","phase":"NA","overall_status":"COMPLETED","enrollment_count":8262,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT04286243","title":"Prevention of Cervical Cancer Through an HPV-based Screen-and-treat Strategy in Malawi","phase":"NA","overall_status":"COMPLETED","enrollment_count":8174,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT06082882","title":"Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 2","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8000,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT03183700","title":"Self Collected Sampling in Non-attendees Cervical Cancer Screening: DNA Test and Molecular Triage for HPV Positive Women","phase":"NA","overall_status":"UNKNOWN","enrollment_count":8000,"lead_sponsor_name":"Cancer Prevention and Research Institute, Italy","has_results":false},{"nct_id":"NCT04422366","title":"Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06872346","title":"Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":7500,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT00128661","title":"Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":7466,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01735006","title":"Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":7372,"lead_sponsor_name":"Xiamen University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}